Exact Sciences Corp (NAS:EXAS)
$ 49.84 -4.24 (-7.84%) Market Cap: 9.20 Bil Enterprise Value: 11.10 Bil PE Ratio: 0 PB Ratio: 2.93 GF Score: 80/100

Exact Sciences Corp at UBS Global Healthcare Virtual Conference Transcript

May 25, 2021 / 08:00PM GMT
Release Date Price: $109.88 (+0.37%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Hey, good afternoon. Welcome. Dan Brennan, coming up towards the back end of day 2 of the UBS Healthcare Conference. Really pleased to be joined with me here with senior management of Exact Sciences. We have CFO, Jeff Elliott. Jeff, actually you have more titles than CFO now I know you've taken on. And Megan Jones, who I don't think will be with us on video who's back from maternity leave, IR, after having twins.

So listen, Jeff, really pleased you could be with us, obviously, and I'm excited to get into the conversation here today.

Jeffrey T. Elliott
Exact Sciences Corporation - Executive VP, CFO & COO

Dan, thanks for having us. It's good to be back.

Questions & Answers

Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Awesome. Maybe just kicking off, Jeff, from a high level. We could jump into

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot